SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-19-000034
Filing Date
2019-05-09
Accepted
2019-05-09 08:02:18
Documents
86
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20190331x10q.htm 10-Q 1553644
2 EX-31.1 petx-20190331xex31_1.htm EX-31.1 20204
3 EX-31.2 petx-20190331xex31_2.htm EX-31.2 20508
4 EX-32.1 petx-20190331xex32_1.htm EX-32.1 7260
5 EX-32.2 petx-20190331xex32_2.htm EX-32.2 7717
6 GRAPHIC petx-20190331x10qg001.jpg GRAPHIC 75710
7 GRAPHIC petx-20190331x10qg002.jpg GRAPHIC 127854
8 GRAPHIC petx-20190331x10qg003.jpg GRAPHIC 76335
  Complete submission text file 0001509190-19-000034.txt   6794003

Data Files

Seq Description Document Type Size
9 EX-101.INS petx-20190331.xml EX-101.INS 1394967
10 EX-101.SCH petx-20190331.xsd EX-101.SCH 52549
11 EX-101.CAL petx-20190331_cal.xml EX-101.CAL 55813
12 EX-101.DEF petx-20190331_def.xml EX-101.DEF 172614
13 EX-101.LAB petx-20190331_lab.xml EX-101.LAB 379951
14 EX-101.PRE petx-20190331_pre.xml EX-101.PRE 338120
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 19808848
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1